ALLO   $2.07  -6.76% Market Closed After Close 2.12 2.42%

Allogene Therapeutics, Inc.
Total Cash 444.63M
totalCashPerShare 2.126
EBITDA -256.56M
Total Debt 94.21M
quickRatio 11.972
currentRatio 12.254
Total Revenue 65.00K
debtToEquity 18.292
Revenue/Share 0.0
ROA -0.23875
ROE -0.4911
grossProfits
freeCashflow -119.75M
operatingCashflow -228.72M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -4166.246
profitMargins 0.0
enterpriseValue 274.83M
forwardPE -2.236111
floatShares 151.31M
sharesOutstanding 209.11M
sharesShort 39.32M
sharesShortPriorMonth 39.19M
dateShortInterest
sharesPercentSharesOut 0.19%
heldPercentInsiders 0.17%
heldPercentInstitutions 0.80%
Short Ratio help_outline 19.93%
shortPercentOfFloat 0.26%
impliedSharesOutstanding
bookValue 2.464
Price To Book help_outline 1.31
earningsQuarterlyGrowth
netIncomeToCommon -279.42M
trailingEps -1.59%
forwardEps -1.44%
enterpriseToEbitda -1.07
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.33 3Q 2024
institutionsCount 238
lastUpdated Nov. 7, 2024, 2:55 a.m.